ES2016682A6 - Procedimiento de preparacion de un polipeptido. - Google Patents

Procedimiento de preparacion de un polipeptido.

Info

Publication number
ES2016682A6
ES2016682A6 ES8803391A ES8803391A ES2016682A6 ES 2016682 A6 ES2016682 A6 ES 2016682A6 ES 8803391 A ES8803391 A ES 8803391A ES 8803391 A ES8803391 A ES 8803391A ES 2016682 A6 ES2016682 A6 ES 2016682A6
Authority
ES
Spain
Prior art keywords
polypeptide
action
spiral
field
transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8803391A
Other languages
English (en)
Inventor
Christopher J Brock
Michael Brian Enser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotechnology and Biological Sciences Research Council
Original Assignee
Biotechnology and Biological Sciences Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878726132A external-priority patent/GB8726132D0/en
Priority claimed from GB888815748A external-priority patent/GB8815748D0/en
Application filed by Biotechnology and Biological Sciences Research Council filed Critical Biotechnology and Biological Sciences Research Council
Publication of ES2016682A6 publication Critical patent/ES2016682A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/30Proteins; Protein hydrolysates
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0008Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
    • C11D17/0017Multi-phase liquid compositions
    • C11D17/0021Aqueous microemulsions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0078Compositions for cleaning contact lenses, spectacles or lenses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S516/00Colloid systems and wetting agents; subcombinations thereof; processes of
    • Y10S516/01Wetting, emulsifying, dispersing, or stabilizing agents
    • Y10S516/06Protein or carboxylic compound containing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Cosmetics (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

ESTE PROCEDIMIENTO PARA PREPARAR UN POLIPEPTIDO, SE REALIZA MEDIANTE CULTIVO DE UNA CELULA HUESPED TRANSFORMADA QUE CONTIENE UNA SECUENCIA DNA QUE ES EXPRESABLE EN LA MENCIONADA CELULA HUESPED BAJO LAS CONDICIONES DE CULTIVO UTILIZADAS, CON EL FIN DE PREPARAR EL INDICADO POLIPEPTIDO POR TRANSCRIPCION DEL DNA EN MRNA Y TRASLACION DEL MRNA AL MATERIAL DEL POLIPEPTIDO, SEGUIDO DE CUANTO MENOS LA PURIFICACION PARCIAL DEL POLIPEPTIDO. ESTOS POLIPEPTIDOS CONSISTEN SUSTANCIALMENTE EN SECUENCIAS DE AMINOACIDOS FORMADORES DE ALFA-ESPIRAL SON UTILES COMO EMULSIONANTES, SI LA ESPIRAL TIENE, POR LO MENOS, UN CAMPO DE ACCION AXIAL HIDROFILICO Y, CUANTO MENOS, UN CAMPO DE ACCION AXIAL HIDROGOBICO, DE TAL MODO QUE LA ESPIRAL PUEDA ADAPTAR UNA ORIENTACION DE LOGARITMO-EN-AGUA EN UNA ZONA INTERFACIAL DE GRASA-AGUA. EL CAMPO DE ACCION HIDROFOBICO PUEDE OCUPAR 80G-280G DEL CIRCULO DEFINIDO POR LA ESPIRAL.
ES8803391A 1987-11-07 1988-11-07 Procedimiento de preparacion de un polipeptido. Expired - Lifetime ES2016682A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878726132A GB8726132D0 (en) 1987-11-07 1987-11-07 Emulsifiers
GB888815748A GB8815748D0 (en) 1988-07-01 1988-07-01 Emulsifiers

Publications (1)

Publication Number Publication Date
ES2016682A6 true ES2016682A6 (es) 1990-11-16

Family

ID=26293004

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8803391A Expired - Lifetime ES2016682A6 (es) 1987-11-07 1988-11-07 Procedimiento de preparacion de un polipeptido.

Country Status (8)

Country Link
US (1) US5330682A (es)
EP (1) EP0387285B1 (es)
JP (1) JPH03505865A (es)
AU (1) AU2609488A (es)
DE (1) DE3887901T2 (es)
ES (1) ES2016682A6 (es)
GR (1) GR1000160B (es)
WO (1) WO1989004209A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU722626B2 (en) * 1996-05-20 2000-08-10 Abburi Ramaiah Cosmetic preparation
AU736707B2 (en) * 1997-06-11 2001-08-02 Anaphore, Inc. Trimerising module
EP2178517B1 (en) * 2007-08-21 2017-01-25 The Regents of The University of California Copolymer-stabilized emulsions
WO2011116411A1 (en) * 2010-03-22 2011-09-29 Pepfactants Pty Ltd Salt-resistant emulsions
US9554995B2 (en) 2012-06-13 2017-01-31 The University Of Queensland Nanoemulsions
GB201409145D0 (en) * 2014-05-22 2014-07-09 Univ Strathclyde Stable emulsions
CN113943353B (zh) * 2021-10-27 2024-05-03 百葵锐(深圳)生物科技有限公司 一种宽应激范围的智能多肽及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0160103B1 (en) * 1983-10-26 1990-06-20 Kanebo, Ltd. Proteinous emulsifier, process for its preparation, and emulsified cosmetic preparation containing same
US4943527A (en) * 1985-10-04 1990-07-24 California Biotechnology Inc. Mature apoai protein production under serum free culturing conditions
US5164369A (en) * 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging

Also Published As

Publication number Publication date
EP0387285B1 (en) 1994-02-16
DE3887901D1 (de) 1994-03-24
US5330682A (en) 1994-07-19
DE3887901T2 (de) 1994-08-18
AU2609488A (en) 1989-06-01
JPH03505865A (ja) 1991-12-19
WO1989004209A1 (en) 1989-05-18
EP0387285A1 (en) 1990-09-19
GR1000160B (el) 1991-10-10

Similar Documents

Publication Publication Date Title
ES2073735T3 (es) Nuevos analogos de la cadena b del factor de crecimiento derivado de plaquetas y metodo para su produccion homogenea.
DE3752319D1 (de) Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert
IT1055354B (it) Ventro ceramica biocompatibile e utilizzazione di questo vetro per la fabbricazione di protesi ossee
LV5288A3 (lv) Nukleinskabes fragments kurs kode cilveka proapolipoproteinu A-1
ATE77104T1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
ES2059354T3 (es) Un metodo para producir un polipeptido.
FI852547L (fi) Framstaellning av faktor viii och daertill hoerande produkter.
DK224587D0 (da) Ekstracellulaer superoxiddismutase (ec-sod), dna-fragment, der indkoder ec-sod, fremgangsmaade til fremstilling af ec-sod samt anvendelse af ec-sod
ES2001152A4 (es) Preparados cosmeticos a base de n - hidroxibutil - quitosanas, nuevasn - hidroxibutil - quitosanas, asi como el procedimiento para su obtencion.
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
DE3678609D1 (de) Partikel mit immunogenen hbs-antigen-eigenschaften und mit einer mit dem hbs-antigen-epitopen nichtverwandten antigenischen stelle, vektoren und tierische zellen fuer die herstellung dieser kombinierten impfstoffartikel.
ES2016682A6 (es) Procedimiento de preparacion de un polipeptido.
DK491487D0 (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
DE69013811D1 (de) Verfahren zur Herstellung von antiviralem Protein unter Benützung von E.coli-Transformant, das Gen, das für dieses Protein kodiert und E.coli-Vektor benützt in diesem Verfahren.
DK164940C (da) Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
ES2068201T3 (es) Produccion de kalicreina.
AR013190A1 (es) Semaforina l humana (h-sema-l) que contiene un dominio de sema caracteristico, un acido nucleico que la codifica, procedimiento para lapreparacion de semaforinas, utilizacion de la semaforina tipo l y utilizacion de la secuencia de acido nucleico para la fabricacion de un medicamento,
AR241794A1 (es) Procedimiento para obtener inteerleucina-2 humana, en una celula de ovario de hamster de la china.
US4882421A (en) Pharmaceutical for treating tumors and method for making it
DE3583634D1 (de) Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
AR019864A1 (es) Proceso para producir el antigeno de toxoplasma sag1 o fragmentos del mismo; proteina sag1 o fragmentos de la misma expresada en dicho proceso;composiciones de vacuna que comprendan dicha proteina sag1 o fragmentos de la misma; uso de dicha proteina para la manufactura de medicamentos para preveniry
ZA935117B (en) Anti-feline immunodeficiency virus (FIV) vaccines
ES2125216T3 (es) Procedimiento para la produccion de polipeptidos recombinantes con actividad de hormona porcina del crecimiento.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-11-07

FD1A Patent lapsed

Effective date: 20010301